Neil Stahl
2014
In 2014, Neil Stahl earned a total compensation of $16.3M as Executive Vice President, Research & Development at Regeneron Pharmaceuticals, a 13% increase compared to previous year.
Compensation breakdown
| Bonus | $532,980 |
|---|---|
| Option Awards | $15,207,420 |
| Salary | $493,500 |
| Other | $20,215 |
| Total | $16,254,115 |
Stahl received $15.2M in option awards, accounting for 94% of the total pay in 2014.
Stahl also received $533K in bonus, $493.5K in salary and $20.2K in other compensation.
Rankings
In 2014, Neil Stahl's compensation ranked 195th out of 13,032 executives tracked by ExecPay. In other words, Stahl earned more than 98.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 195 out of 13,032 | 99th |
Division Manufacturing | 72 out of 4,967 | 99th |
Major group Chemicals And Allied Products | 28 out of 1,690 | 98th |
Industry group Drugs | 25 out of 1,369 | 98th |
Industry Pharmaceutical Preparations | 23 out of 1,042 | 98th |
Source: SEC filing on April 26, 2016.
Stahl's colleagues
We found four more compensation records of executives who worked with Neil Stahl at Regeneron Pharmaceuticals in 2014.
2014
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2014
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
2014
Robert Terifay
Regeneron Pharmaceuticals
Executive Vice President, Commercial
2014
Robert Landry
Regeneron Pharmaceuticals